Skip to main content
. 2018 Aug 6;9(17):3058–3066. doi: 10.7150/jca.26060

Table 3.

The risk grading of patients between two periods

Risk Grading 2015.10-2016.7 2016.8-2017.5 P value*
Nodules no. Patients no**. Nodules no. Patients no**.
0, Low risk 64(8.5%) 3(1.5%) 45(7.2%) 2(1.1%) Nodules:
0.267
1, Medium risk 278(36.8%) 27(13.9%) 237(37.9%) 26(13.8%)
2, High risk 79(10.4%) 9(4.6%) 49(7.8%) 8(4.3%) Patients:
0.975
3, Very high risk 335(44.3%) 155(80.0%) 295(47.1%) 152(80.8%)

* P value was calculated using the Chi-square test.

** The risk of patients was determined based on the highest risk of their nodules.